Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), David García-Illescas(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Anna Pous(Institut Català d'Oncologia), Lorenza Scotti(University of Milano-Bicocca), Joanne Evans, Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Eve Merry(Royal London Hospital), Diego Ottaviani(Royal London Hospital), John Chester(Velindre Cancer Centre), Nadia Harbeck(Breast Center), Alessandro Parisi(Marche Polytechnic University), Maristella Saponara(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Alberto Zambelli, Alexia Bertuzzi(Humanitas University), Michela Libertini(Fondazione Poliambulanza Istituto Ospedaliero), Ramón Salazar(Institut Català d'Oncologia), Vittoria Fotia(Ospedale Papa Giovanni XXIII), Ailsa Sita-Lumsden(Guy's and St Thomas' NHS Foundation Trust), Sabrina Rossi(IRCCS Humanitas Research Hospital), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo Tondini(Ospedale Papa Giovanni XXIII), Saoirse Dolly(Guy's and St Thomas' NHS Foundation Trust), Uma Mukherjee(University College London Hospitals NHS Foundation Trust), Joan Brunet(Institut Català d'Ornitologia), Johann Colomba(Guy's and St Thomas' NHS Foundation Trust), Charlotte Moss(Southampton General Hospital), Meera Patel(Wayne State University), Mark Bower(Chelsea and Westminster Hospital), Émeline Colomba(Université Paris-Saclay), Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Krishnie Srikandarajah(Guy's and St Thomas' NHS Foundation Trust), Federica Biello(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Marco Tagliamento(Ospedale Policlinico San Martino), Bruno Vincenzi(Campus Bio Medico University Hospital), Alessia Dalla Pria(Hammersmith Hospital), Fanny Pommeret(Université Paris-Saclay), Matteo Lambertini(Ospedale Policlinico San Martino), Angela Loizidou(Université Libre de Bruxelles), Beth Russell(King's College London), Alice Baggi(Vall d'Hebron Hospital Universitari), Elia Seguí, Giampero Porzio(University of L'Aquila), Amani Chowdhury(Royal London Hospital), Claudia Andrea Cruz(Ospedale Papa Giovanni XXIII), Raquel Liñan(Institut Català d'Oncologia), Laura Fox(Ospedale Papa Giovanni XXIII), Gianpiero Rizzo(Policlinico San Matteo Fondazione), Josep Tabernero(Vall d'Hebron Hospital Universitari), M. Carmen Carmona-García(München Klinik)
Cited by 136
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k